Exact Mass: 839.4666963999999

Exact Mass Matches: 839.4666963999999

Found 7 metabolites which its exact mass value is equals to given mass value 839.4666963999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ala-Thr-Trp-Leu-Pro-Pro-Arg

2-[({1-[1-(2-{[2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,3-dihydroxybutylidene}amino)-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-methylpentanoyl)pyrrolidine-2-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-5-carbamimidamidopentanoate

C40H61N11O9 (839.4653496000001)


   
   

(2R)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C47H70NO10P (839.473709)


   
   
   
   

ATWLPPR Peptide

ATWLPPR Peptide

C40H61N11O9 (839.4653496000001)


ATWLPPR Peptide is a biological active peptide. (This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in-vivo. It specifically inhibits human endothelial cell proliferation in-vitro and totally abolishes VEGF-induced angiogenesis in-vivo.)